Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Tablet Disintegration Testing

Posted on By

SOP for Tablet Disintegration Testing

Procedure for Tablet Disintegration Testing

1) Purpose

The purpose of this SOP is to outline the procedure for testing the disintegration of tablets to ensure they dissolve completely within the specified time frame for effective drug release.

2) Scope

This SOP applies to all tablet batches produced within the manufacturing facility.

3) Responsibilities

Quality Control (QC) Department: Responsible for conducting disintegration testing and ensuring compliance with this SOP.
Production Department: Responsible for providing tablet samples for testing and maintaining process parameters.

4) Procedure

4.1 Sampling:
    4.1.1 Collect a representative sample of tablets from different locations within a batch according to the sampling plan.
    4.1.2 Ensure the sample size is adequate (e.g., 6 tablets) to obtain a uniform representation.

See also  SOP for Environmental Monitoring in Cleanrooms

4.2 Equipment Preparation:
    4.2.1 Set up the disintegration tester as per the manufacturer’s instructions.
    4.2.2 Ensure the tester is clean and calibrated.

4.3 Disintegration Testing Procedure:
    4.3.1 Place one tablet in each tube of the disintegration tester.
    4.3.2 Immerse the tablets in the specified dissolution medium (e.g., distilled water at 37°C).
    4.3.3 Operate the tester for the specified time (e.g., 30 minutes).
    4.3.4 Observe each tablet to ensure it has completely disintegrated into particles small enough to pass through the mesh of the basket or to be retained

on the mesh.
    4.3.5 Record the time taken for each tablet to disintegrate completely.

See also  SOP for Capsule Content Uniformity

4.4 Acceptance Criteria:
    4.4.1 The tablet batch is acceptable if all tablets disintegrate within the specified time limit (e.g., not more than 30 minutes).

4.5 Documentation:
    4.5.1 Document all results and observations in the Tablet Disintegration Test Record.
    4.5.2 Review and approve the documentation by QC Manager.

5) Abbreviations, if any

QC: Quality Control

6) Documents, if any

Tablet Disintegration Test Record
Calibration Record for Disintegration Tester
Sampling Plan Document

7) Reference, if any

USP <701> – Disintegration
21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals

8) SOP Version

Version 1.0

In-Process Control Tags:Blend uniformity testing SOP, Bulk density testing SOP, Capsule content uniformity SOP, Capsule disintegration testing SOP, Capsule dissolution testing SOP, Capsule weight variation SOP, Clarity and opalescence testing of liquids SOP, Endotoxin testing in injectable products SOP, Flowability testing of powders SOP, Granulation size distribution SOP, Moisture content determination in granules SOP, Osmolality testing SOP, Particulate matter testing in liquids SOP, pH measurement of solutions SOP, Pyrogen testing SOP, Specific gravity testing of liquids SOP, Sterility testing SOP, Tablet disintegration testing SOP, Tablet dissolution testing SOP, Tablet friability testing SOP, Tablet hardness testing SOP, Tablet thickness measurement SOP, Tablet weight variation SOP, Uniformity of dosage units SOP, Viscosity testing of liquids SOP

Post navigation

Previous Post: SOP for Process Validation in Ointment Formulation
Next Post: SOP for Sealing Integrity Check: Ensuring That the Capsules Are Properly Sealed to Prevent Leakage and Maintain Product Integrity

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version